Tasly Pharmaceutical Group Co Ltd banner

Tasly Pharmaceutical Group Co Ltd
SSE:600535

Watchlist Manager
Tasly Pharmaceutical Group Co Ltd Logo
Tasly Pharmaceutical Group Co Ltd
SSE:600535
Watchlist
Price: 14.22 CNY 2.38%
Market Cap: ¥21.2B

Wall Street
Price Targets

Price Targets Summary
Tasly Pharmaceutical Group Co Ltd

Wall Street analysts forecast Tasly Pharmaceutical Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Tasly Pharmaceutical Group Co Ltd is 17.32 CNY with a low forecast of 14.14 CNY and a high forecast of 19.95 CNY.

Lowest
Price Target
14.14 CNY
1% Downside
Average
Price Target
17.32 CNY
22% Upside
Highest
Price Target
19.95 CNY
40% Upside
Tasly Pharmaceutical Group Co Ltd Competitors:
Price Targets
JEF
Jefferies Financial Group Inc
105% Upside

Revenue
Forecast

2% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
2% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 13 years the compound annual growth rate for Tasly Pharmaceutical Group Co Ltd's revenue is 2%. The projected CAGR for the next 4 years is 2%.

Operating Income
Forecast

6% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
6% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 13 years the compound annual growth rate for Tasly Pharmaceutical Group Co Ltd's operating income is 6%. The projected CAGR for the next 4 years is 15%.

Net Income
Forecast

4% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
4% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

For the last 13 years the compound annual growth rate for Tasly Pharmaceutical Group Co Ltd's net income is 4%. The projected CAGR for the next 4 years is 23%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Tasly Pharmaceutical Group Co Ltd's stock price target?
Price Target
17.32 CNY

According to Wall Street analysts, the average 1-year price target for Tasly Pharmaceutical Group Co Ltd is 17.32 CNY with a low forecast of 14.14 CNY and a high forecast of 19.95 CNY.

What is Tasly Pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
2%

For the last 13 years the compound annual growth rate for Tasly Pharmaceutical Group Co Ltd's revenue is 2%. The projected CAGR for the next 4 years is 2%.

What is Tasly Pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
15%

For the last 13 years the compound annual growth rate for Tasly Pharmaceutical Group Co Ltd's operating income is 6%. The projected CAGR for the next 4 years is 15%.

What is Tasly Pharmaceutical Group Co Ltd's Net Income forecast?
Projected CAGR
23%

For the last 13 years the compound annual growth rate for Tasly Pharmaceutical Group Co Ltd's net income is 4%. The projected CAGR for the next 4 years is 23%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett